Combined cord blood stem cells and gene therapy enhances angiogenesis and improves cardiac performance in mouse after acute myocardial infarction.
about
Gene therapy for ischemic heart diseaseSafety and efficacy of bone marrow-derived autologous CD133+ stem cell therapy.Targeted Genome Engineering to Control VEGF Expression in Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells: Potential Implications for the Treatment of Myocardial Infarction.The potential of cord blood stem cells for use in regenerative medicine.Cell-based regenerative strategies for treatment of diabetic skin wounds, a comparative study between human umbilical cord blood-mononuclear cells and calves' blood haemodialysateTherapeutic myocardial angiogenesisHuman Umbilical Cord Blood for Transplantation Therapy in Myocardial Infarction.CD34-positive stem cells: in the treatment of heart and vascular disease in human beingsHuman umbilical cord blood-derived mononuclear cells improve murine ventricular function upon intramyocardial delivery in right ventricular chronic pressure overload.Analysis of the efficiency of gene-cell therapy in transgenic mice with amyotrophic lateral sclerosis phenotype.Spinal Cord Molecular and Cellular Changes Induced by Adenoviral Vector- and Cell-Mediated Triple Gene Therapy after Severe Contusion.Genipin-cross-linked microencapsulated human adipose stem cells augment transplant retention resulting in attenuation of chronically infarcted rat heart fibrosis and cardiac dysfunction.Triple-Gene Therapy for Stroke: A Proof-of-Concept in Vivo Study in Rats.Stem Cell Banking for Regenerative and Personalized Medicine.Human umbilical cord blood mononuclear cells decrease fibrosis and increase cardiac function in cardiomyopathy.Genetically modified human umbilical cord blood cells expressing vascular endothelial growth factor and fibroblast growth factor 2 differentiate into glial cells after transplantation into amyotrophic lateral sclerosis transgenic mice.
P2860
Q24632135-8E9FD0B3-B97E-4BD2-B28D-6161846ADF54Q30428262-1C3A8AFB-B7A0-41D6-99B3-D28AC5E53004Q33722274-72460D9B-D4A6-400A-93DF-F705062FBB6BQ34582143-DC12027F-0A71-45AF-9E45-DB8282868D1BQ35124214-18BCEA01-9400-4C34-ABE6-220371C0BC96Q36976439-9B76986D-19EF-4050-875A-30AA881E93BBQ37353891-16C06F9E-160B-40FB-9869-B448EE40EE10Q37967719-392480EF-FC74-496E-95DD-0E966FD1EF78Q40148414-216CB4FD-1C86-4C8F-A1B4-53DED85FF1F2Q43691174-7FB915BC-7E76-4D58-8288-9850E426C02BQ45875097-733F5A14-5DB2-447D-9912-A64D5259B92DQ47898227-460738D8-F190-44DA-B1BE-3FA9DDB04E8DQ50350373-DA016853-8390-4017-BDF3-10067F267D36Q51301197-505784C2-F885-4630-868F-ED365CC4A7A4Q51775681-33D601B3-ED80-432A-93A9-BFCD39E3C1CEQ54396902-CE4C6CBD-EC58-4EEC-8075-5138A25D103D
P2860
Combined cord blood stem cells and gene therapy enhances angiogenesis and improves cardiac performance in mouse after acute myocardial infarction.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Combined cord blood stem cells ...... r acute myocardial infarction.
@en
Combined cord blood stem cells ...... r acute myocardial infarction.
@nl
type
label
Combined cord blood stem cells ...... r acute myocardial infarction.
@en
Combined cord blood stem cells ...... r acute myocardial infarction.
@nl
prefLabel
Combined cord blood stem cells ...... r acute myocardial infarction.
@en
Combined cord blood stem cells ...... r acute myocardial infarction.
@nl
P2093
P2860
P1476
Combined cord blood stem cells ...... r acute myocardial infarction.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2362.2005.01565.X
P577
2005-11-01T00:00:00Z